Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2001Diabetic Medicine

Beta‐cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMariano J. TavernaNPNathalie PacherInsermFBF. BruzzoInserm

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Taverna et al. (2001) studied this question.

synapsesocial.com/papers/6a891dca185d41e08f760186https://doi.org/10.1046/j.1464-5491.2001.00534.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes.1999 · 187 citations
  2. 2UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years1998 · 439 citations
  3. 3Insulin Use in NIDDM1990 · 117 citations
  4. 4Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study1998 · 289 citations